The efficacy of combination therapy with docetaxel and the anti-angiogenic peptide, VGB3, in a 4T1 triple-negative breast cancer model

Document Type : Animal Research

Researchers

• Mohsen Asghari ¹
• Farangis Ataei ²
• Saman Hoseinkhani ²
• Majid Mahdavi ³
• Maryam Suraneh ¹

¹ Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran

² Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

³ Biochemistry, Institute of Biochemistry and Biophysics, Tehran, Iran

Ministerial Ethics Committee

Approval ID

• Peptide
• Docetaxel
• Combination Therapy
• Cancer

Main Subjects

• Other